There are numerous DIPG trials available worldwide (subject to eligibility criteria) however there is only very limited scope in the UK available on the NHS.
Currently though new studies are in development there are NO recruiting National trials for 'newly diagnosed' patients with DIPG available.
We are working as hard as we can around the 'unmet needs' of DIPG patients to bring forward any new clinical opportunities for UK children as quickly as possible.
The only previous national approach and 'molecularly targeted' trial 'BIOMEDE 1.0' is ongoing study and CLOSED to recruitment. BIOMEDE 2.0 will open shortly in the UK utilising ONC201 and Everolimus for newly diagnosed patients.
We want all UK patients to have a choice of valid options that are available at home, so that no child has to raise funds or travel for overseas treatments and trials.
The full list of open European and US trials with all their locations can be found on the 'Worldwide Clinical Trials' tab.
